Effect of Lacosamide monotherapy on sleep architecture in patients with epilepsy
Effect of Lacosamide monotherapy on sleep architecture in patients with epilepsy

Effect of Lacosamide monotherapy on sleep architecture in patients with epilepsy

The research aimed to assess the impact of Lacoamide monotherapy (LCM) on sleep among individuals with focal epilepsy. Findings indicated that LCM monotherapy had a positive influence on sleep architecture in these patients. Notably, improvements in sleep efficiency, decreased sleep latency, and reduced wakefulness after sleep onset were observed during follow-up, suggesting enhanced sleep stability and continuity for individuals undergoing LCM treatment.

要查看或添加评论,请登录

Connect2Clinic的更多文章

社区洞察

其他会员也浏览了